Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Tumour cyclic AMP binding proteins and endocrine responsiveness in patients with inoperable breast cancer.

× No keyword cloud information.

10 in total

1. Cyclic AMP-binding proteins: inverse relationship with estrogen-receptors in hormone-dependent mammary tumor regression.

Authors: Y S Cho-Chung; J S Bodwin; T Clair
Journal: Eur J Biochem Date: 1978-05

2. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors: M M Bradford
Journal: Anal Biochem Date: 1976-05-07 Impact factor: 3.365

Review 3. Physiological and pharmacological effects of estrogens in breast cancer.

Authors: G Leclercq; J C Heuson
Journal: Biochim Biophys Acta Date: 1979-12-19

4. Estrogen and progesterone receptor proteins in breast cancer.

Authors: D P Edwards; G C Chamness; W L McGuire
Journal: Biochim Biophys Acta Date: 1979-12-19

5. Dibutyryl cyclic AMP mimics ovariectomy: nuclear protein phosphorylation in mammary tumor regression.

Authors: Y S Cho-Chung; B H Redler
Journal: Science Date: 1977-07-15 Impact factor: 47.728

6. Relationship of hormone dependency to estrogen receptor and adenosine 3',5'-cyclic monophosphate-binding proteins in rat mammary tumors.

Authors: J S Bodwin; T Clair; Y S Cho-Chung
Journal: J Natl Cancer Inst Date: 1980-02 Impact factor: 13.506

Review 7. Steroid hormone receptors in the management of human breast cancer.

Authors: W A Knight; C K Osborne; M G Yochmowitz; W L McGuire
Journal: Ann Clin Res Date: 1980-10

8. Oestrogen receptor concentration in primary breast cancer and axillary node metastases.

Authors: R A Hawkins; R Black; R J Steele; J M Dixon; A P Forrest
Journal: Breast Cancer Res Treat Date: 1981 Impact factor: 4.872

9. Relationship of cyclic AMP binding capacity and estrogen receptor to hormone sensitivity in human breast cancer.

Authors: S Kvinnsland; R Ekanger; S O Døskeland; T Thorsen
Journal: Breast Cancer Res Treat Date: 1983 Impact factor: 4.872

10. Variations in steroid receptors and cyclic AMP binding proteins across human breast cancers: evidence for heterogeneity.

Authors: R O Senbanjo; W R Miller; R A Hawkins
Journal: Br J Cancer Date: 1986-07 Impact factor: 7.640

10 in total

6 in total

Review 1. Genetic predisposition to peripheral nerve neoplasia: diagnostic criteria and pathogenesis of neurofibromatoses, Carney complex, and related syndromes.

Authors: Fausto J Rodriguez; Constantine A Stratakis; D Gareth Evans
Journal: Acta Neuropathol Date: 2011-12-31 Impact factor: 17.088

2. Ala99ser mutation in RI alpha regulatory subunit of protein kinase A causes reduced kinase activation by cAMP and arrest of hormone-dependent breast cancer cell growth.

Authors: G R Lee; S N Kim; K Noguchi; S D Park; S H Hong; Y S Cho-Chung
Journal: Mol Cell Biochem Date: 1999-05 Impact factor: 3.396

Review 3. The lentiginoses: cutaneous markers of systemic disease and a window to new aspects of tumourigenesis.

Authors: A J Bauer; C A Stratakis
Journal: J Med Genet Date: 2005-06-15 Impact factor: 6.318

4. Cyclic AMP binding proteins and prognosis in breast cancer.

Authors: W R Miller; R A Elton; J M Dixon; U Chetty; D M Watson
Journal: Br J Cancer Date: 1990-02 Impact factor: 7.640

5. Differential expression of cAMP-kinase subunits is correlated with growth in rat mammary carcinomas and uterus.

Authors: G Houge; Y S Cho-Chung; S O Døskeland
Journal: Br J Cancer Date: 1992-12 Impact factor: 7.640

6. Outcome after extended follow-up in a prospective study of operable breast cancer: key factors and a prognostic index.

Authors: R A Hawkins; A L Tesdale; R J Prescott; T Forster; M A McIntyre; P Baker; W J L Jack; U Chetty; J M Dixon; M E Killen; M J Hulme; W R Miller
Journal: Br J Cancer Date: 2002-07-01 Impact factor: 7.640

6 in total